SHPG Share Price

Open 170.00 Change Price %
High 171.59 1 Day -0.44 -0.26
Low 168.55 1 Week 5.33 3.25
Close 169.36 1 Month -2.45 -1.43
Volume 1569559 1 Year -22.07 -11.53
52 Week High 209.22
52 Week Low 158.54
SHPG Important Levels
Resistance 2 172.18
Resistance 1 171.02
Pivot 169.83
Support 1 167.70
Support 2 166.54
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
ASTI 0.00 0.00%
FNFG 10.18 -0.20%
QQQ 143.96 -0.63%
SIRI 5.83 8.16%
FB 170.44 2.92%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
SHOR 7.50 28.21%
OPNT 14.53 27.46%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
LPSN 13.50 18.42%
TREE 217.15 18.14%
AXTI 8.80 15.79%
DRYS 1.20 15.38%
More..
NASDAQ USA Top Losers Stocks
EDMC 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
IPCI 1.36 -45.38%
DVOX 0.05 -44.44%
GLCH 0.70 -44.00%
More..

Shire plc (NASDAQ: SHPG)

SHPG Technical Analysis 4
As on 27th Jul 2017 SHPG Share Price closed @ 169.36 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 177.03 & Sell for SHORT-TERM with Stoploss of 171.46 we also expect STOCK to react on Following IMPORTANT LEVELS.
SHPG Target for July
1st Target up-side 174.07
2nd Target up-side 180.24
3rd Target up-side 186.41
1st Target down-side 156.47
2nd Target down-side 150.3
3rd Target down-side 144.13
Shire plc ( NASDAQ USA Symbol : SHPG )
Sector : N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various And Other Stocks in Same Sector
SHPG
169.36 -0.44 (-0.26 %)
LT : Strong Sell
ST : Sell
SHPG Other Details
Segment EQ
Market Capital 16032273408.00
Sector N/AIndustry:N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together with its subsidiaries, researches, develops, licenses, manufactures, markets, distributes, and sells pharmaceutical products. It offers various
Industry N/AFull Time Employees:5,338Business Summary Shire plc, a biopharmaceutical company, together w
Offical website http://www.shire.com
SHPG Address
SHPG
5 Riverwalk
Citywest Business Campus
Dublin, 24
Ireland
Phone: 353 1 429 7700
SHPG Latest News
Interactive Technical Analysis Chart Shire plc ( SHPG NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Shire plc
SHPG Business Profile
Shire plc (Shire) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), gastrointestinal (GI) diseases, human genetic therapies (HGT) and regenerative medicine (RM), as well as opportunities in other therapeutic areas. On January 31, 2012, the United States Food and Drug Administration approved VYVANSE for the maintenance treatment of ADHD in adults. In March 2013, it announced the acquisition Of Premacure AB. In January 2014, Shire Plc sold its DERMAGRAFT assets to Organogenesis Inc. In January 2014, Shire Plc acquired 79.5% interest in ViroPharma Inc.